X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (522) 522
male (322) 322
female (316) 316
hematology (284) 284
adult (281) 281
middle aged (274) 274
blast crisis (220) 220
oncology (220) 220
index medicus (209) 209
aged (199) 199
prognosis (192) 192
chronic myelogenous leukemia (158) 158
leukemia, myelogenous, chronic, bcr-abl positive - mortality (149) 149
adolescent (147) 147
leukemia, myelogenous, chronic, bcr-abl positive - pathology (131) 131
survival rate (128) 128
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (120) 120
blast crisis - mortality (114) 114
blast crisis - pathology (113) 113
chronic myeloid leukemia (110) 110
imatinib mesylate (107) 107
treatment outcome (106) 106
aged, 80 and over (93) 93
survival analysis (93) 93
leukemia, myelogenous, chronic, bcr-abl positive - genetics (88) 88
benzamides (86) 86
leukemia (86) 86
chronic myeloid-leukemia (84) 84
blast crisis - drug therapy (83) 83
retrospective studies (81) 81
child (80) 80
leukemia, myelogenous, chronic, bcr-abl positive - therapy (76) 76
antineoplastic agents - therapeutic use (75) 75
antineoplastic combined chemotherapy protocols - therapeutic use (74) 74
remission induction (71) 71
disease-free survival (66) 66
chemotherapy (62) 62
young adult (61) 61
imatinib (60) 60
blast crisis - genetics (59) 59
cancer (59) 59
pyrimidines - therapeutic use (58) 58
acute lymphoblastic-leukemia (56) 56
follow-up studies (56) 56
piperazines - therapeutic use (56) 56
transplantation (55) 55
leukemia, myeloid, acute - mortality (54) 54
survival (53) 53
bcr-abl (52) 52
therapy (52) 52
cml (51) 51
philadelphia-chromosome (51) 51
child, preschool (50) 50
blast crisis - therapy (49) 49
research (48) 48
fusion proteins, bcr-abl - genetics (46) 46
time factors (46) 46
animals (45) 45
risk factors (45) 45
stem cells (45) 45
philadelphia chromosome (44) 44
pyrimidines - administration & dosage (43) 43
bone marrow transplantation (42) 42
cytogenetic responses (42) 42
hemic and lymphatic diseases (41) 41
disease progression (40) 40
piperazines - administration & dosage (40) 40
transplantation, homologous (40) 40
hematology, oncology and palliative medicine (39) 39
protein kinase inhibitors - therapeutic use (38) 38
bone marrow - pathology (37) 37
abl tyrosine kinase (36) 36
cytarabine - administration & dosage (36) 36
leukemia, myeloid, acute - pathology (36) 36
analysis (35) 35
blast crisis - blood (34) 34
chronic-phase (34) 34
explosions (34) 34
acute myeloid-leukemia (33) 33
care and treatment (33) 33
chromosome aberrations (33) 33
hematopoietic stem cell transplantation (33) 33
interferon-alpha (33) 33
leukemia, myeloid - mortality (33) 33
medicine & public health (33) 33
mutation (31) 31
precursor cell lymphoblastic leukemia-lymphoma - mortality (31) 31
recurrence (31) 31
leukemia, myeloid, acute - drug therapy (30) 30
combined modality therapy (29) 29
immunology (29) 29
infant (29) 29
leukocyte count (29) 29
stem-cell transplantation (29) 29
acute myeloid leukemia (28) 28
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (28) 28
acute disease (27) 27
dasatinib (27) 27
leukemia, myeloid - pathology (27) 27
abridged index medicus (26) 26
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (544) 544
German (11) 11
Spanish (8) 8
Russian (6) 6
Polish (3) 3
Japanese (2) 2
Italian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 04/2008, Volume 111, Issue 7, pp. 3395 - 3402
Journal Article
Blood, ISSN 0006-4971, 05/2002, Volume 99, Issue 10, pp. 3530 - 3539
Journal Article
Blood, ISSN 0006-4971, 01/2008, Volume 111, Issue 2, pp. 574 - 582
Journal Article
Journal Article
Cancer, ISSN 0008-543X, 11/2017, Volume 123, Issue 22, pp. 4391 - 4402
BACKGROUND Outcomes in patients with chronic myeloid leukemia in blast phase (CML‐BP) are historically dismal. Herein, the authors sought to analyze the... 
tyrosine kinase inhibitors (TKI) | dasatinib | nilotinib | imatinib | ponatinib | blast phase (BP) | bosutinib | chronic myeloid leukemia (CML) | CHRONIC MYELOGENOUS LEUKEMIA | CML | MANAGEMENT | ABNORMALITIES | SENSITIVITY | MECHANISMS | ONCOLOGY | CRISIS | MUTATIONS | Blast Crisis - drug therapy | Prognosis | Humans | Middle Aged | Risk Factors | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Male | Young Adult | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - diagnosis | Protein Kinase Inhibitors - therapeutic use | Adolescent | Blast Crisis - mortality | Survival Analysis | Aged, 80 and over | Blast Crisis - diagnosis | Adult | Female | Aged | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - mortality | Cohort Studies | Protein-Tyrosine Kinases - antagonists & inhibitors | Cancer patients | Chemotherapy | Usage | Patient outcomes | Chronic myeloid leukemia | Health aspects | Cancer | Transformation | Dehydrogenases | Leukemia | Stem cell transplantation | Transplantation | Blast | Multivariate analysis | Parameter identification | Dehydrogenase | Historical account | Failure analysis | Chromosome 15 | Protein-tyrosine kinase | Age | Tyrosine | Phase transformations | Myeloid leukemia | Abnormalities | Lactate dehydrogenase | Regression analysis | Patients | Survival | L-Lactate dehydrogenase | Inhibitors | Medical prognosis | Stem cells | Lactic acid | Aberration | Platelets
Journal Article
Leukemia, ISSN 0887-6924, 2013, Volume 27, Issue 11, pp. 2254 - 2256
Journal Article
Leukemia Research, ISSN 0145-2126, 2015, Volume 39, Issue 9, pp. 950 - 956
Journal Article
Blood, ISSN 0006-4971, 09/2002, Volume 100, Issue 6, pp. 1965 - 1971
Journal Article
Journal Article